Site 601-002 — Cincinnati, Ohio

Site 601-002 is a clinical research site located in Cincinnati, Ohio, United States 45236.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 601-002 has participated in 1 clinical trials.

Therapeutic areas: Chronic Spontaneous Urticaria.

Sponsors: Allakos Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 601-002?

Site 601-002 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 601-002 conducted?

Site 601-002 has 1 clinical trials on record. Their work covers Chronic Spontaneous Urticaria.

Is Site 601-002 accredited by Crixeo Health?

Site 601-002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 601-002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.